IE stock · Healthcare sector · Medical Devices
Company Logo

Medtronic plc

MDTNYSE

82.58

USD
+0.74
(+0.90%)
Market Closed
25.65P/E
15Forward P/E
1.29P/E to S&P500
109.846BMarket CAP
3.20%Div Yield

Medtronic plc

NYSE:MDT

RECENT
PRICE

82.58

P/E
RATIO

25.65

(PEG:0.64)

P/E RATIO
RELATIVE
TO S&P

1.29

DIV
YLD

2.87%

High:
Low:

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

Legends

Stock price

0.72 Beta (1.0 Market)

0

0

0

0

0

0

0

0

0

-

% total return 01/23:

Stock

S&P

1y.

0

0

3y.

0

0

5y.

0

0

0

Percent shares traded:

0

0

0

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

Fiscal year

10.70

2.44

1.99

0.44

11.95

1.97

2.55

0.50

13.06

1.94

2.88

0.75

14.30

2.80

3.16

0.82

14.79

2.87

2.96

0.90

15.36

3.43

3.77

0.97

16.28

3.40

4.34

1.04

16.97

3.06

4.55

1.11

18.49

2.44

3.95

1.22

20.45

2.51

2.96

1.52

21.55

2.92

4.08

1.72

22.08

2.29

2.67

1.84

22.70

3.44

4.36

2.00

21.57

3.57

4.49

2.16

22.39

2.68

3.63

2.32

23.60

3.75

4.45

2.52

23.08

3.23

3.61

2.62

Revenue per share

Earnings per share

Free Cash Flow per sh

Dividends per share

0.60

9.55

0.54

10.20

0.59

11.50

0.57

13.22

0.51

14.82

0.47

16.24

0.45

18.32

0.40

19.40

0.52

48.59

0.74

36.93

0.91

36.47

0.79

37.38

0.84

37.20

0.90

37.84

1.01

38.24

1.02

39.15

1.10

39.26

CAPEX per share

Book Value per share

1,150

1,131

1,118

1,106

1,077

1,054

1,019

1,002

1,096

1,410

1,379

1,357

1,346

1,341

1,345

1,342

1,335

Comm.Shares outs.(m)

21.2

1.2

0.8%

23.7

1.1

1.1%

18.0

0.3

2.2%

13.9

0.7

2.1%

12.9

0.8

2.4%

11.6

0.8

2.4%

15.1

0.9

2.0%

20.6

1.1

1.8%

30.4

1.5

1.6%

31.9

1.4

1.9%

27.8

1.2

2.1%

38.4

1.5

2.1%

28.7

1.2

2.0%

28.6

0.8

2.1%

45.3

1.5

1.9%

25.2

1.2

2.7%

25.6

1.3

2.9%

Avg. annual P/E ratio

P/E relative to S&P500

Avg. annual div. yield

Capital Structure (28/10/22 | Q2)

Total liabilities
$41,184 m.

Total assets
$93,241 m.

Long-term debt
$20,753 m.

Cash and equiv.
$4,828 m.

Goodwill $40,417 m.

Retained earnings $29,799 m.

Common stock 1,329 m. shares

Market Capitalisation
$109,846 m. (as of 29/1/23)

16,184

29.9%

16,590

28.8%

17,005

28.3%

20,261

18.6%

28,833

18.4%

29,710

17.9%

29,953

22.2%

30,557

20.5%

28,913

16.6%

30,117

14.9%

31,686

18.2%

30,808

19.0%

Revenue (m)

Operating margin

833

3,617

819

3,467

850

3,065

1,306

2,675

2,820

3,538

2,917

4,028

2,644

3,104

2,659

4,631

2,663

4,789

2,702

3,606

2,707

5,039

2,699

4,321

Depreciation (m)

Net profit (m)

17.6%

22.3%

18.4%

20.9%

17.3%

18.0%

23.3%

13.2%

18.4%

12.3%

12.6%

13.6%

45.5%

10.4%

10.5%

15.2%

(18.5)%

16.6%

6.8%

12.0%

8.3%

15.9%

23.3%

13.9%

Income tax rate

Net profit margin

3,658

7,359

17,113

13,902

9,560

18,671

15,651

10,259

19,443

21,671

33,673

53,230

16,435

30,158

52,063

10,653

25,881

50,294

12,896

23,705

50,720

13,495

24,477

50,091

11,665

22,021

50,737

14,039

26,378

51,428

10,665

20,372

52,551

10,933

20,753

51,880

Working capital (m)

Long-term debt (m)

Equity (m)

14.2%

14.2%

21.1%

12.2%

13.3%

18.6%

10.4%

10.8%

15.8%

3.3%

3.9%

5.0%

5.0%

5.7%

6.8%

5.8%

5.7%

8.0%

4.6%

7.5%

6.1%

7.3%

7.4%

9.2%

7.6%

5.7%

9.4%

5.3%

5.2%

7.0%

7.1%

6.7%

9.6%

6.0%

6.6%

8.3%

ROIC

Return on capital

Return on equity

Working Capital

2020

2021

2022

Cash assets

10,948

10,401

10,522

Receivables

4,645

5,462

5,551

Inventory

4,229

4,313

4,616

Other

2,209

1,956

2,319

Current assets

22,031

22,548

23,059

Acc. Payable

1,996

2,106

2,276

Debt due

2,776

11

3,742

Other

5,594

6,392

6,376

Current liab.

10,366

8,509

12,394

(Infinity)%

59.6%

69.6%

46.0%

63.6%

51.8%

50.0%

60.2%

39.5%

107.3%

41.0%

97.6%

19.4%

117.9%

42.1%

77.9%

39.8%

59.1%

14.0%

67.5%

33.2%

92.0%

19.5%

113.4%

Plowback ratio

Div.&Repurch. to FCF

Medtronic plc (IE) started trading on March 1, 1980 (cik: 0001613103), operates in the Healthcare sector (Medical Devices industry), has 95,000 full-time employees, and is led by Mr. Omar Ishrak. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Annual rates

(avg rate of change)

Past
5 y.

Past
10 y.

Revenues

1.50%

8.20%

Cash flow

17.11%

6.88%

Earnings

16.91%

7.39%

Dividends

7.92%

14.81%

Book value

0.90%

19.64%

Insider trading

Type

Shares

Date

Salmon Sean

Exempt

14,823

12/13/22

Salmon Sean

Sale

16,631

12/13/22

Salmon Sean

Exempt

14,823

12/13/22

Salmon Sean

Exempt

1,808

12/13/22

Fong Ivan K

InKind

5,206

12/09/22

Fiscal Year Ends

Quarterly Revenue (m)

Full fiscal year

I

II

III

IV

2021

6,507

7,647

7,775

8,188

30,117

2022

7,987

7,847

7,763

8,089

31,686

2023

7,371

7,585

- -

- -

- -

Fiscal Year Ends

Earnings per share

Full fiscal year

I

II

III

IV

2021

0.36

0.36

0.94

1.01

2.68

2022

0.57

0.98

1.10

1.11

3.75

2023

0.70

0.32

- -

- -

- -

Fiscal Year Ends

Quarterly dividends paid

Full fiscal year

I

II

III

IV

2021

0.58

0.58

0.58

0.58

2.32

2022

0.63

0.63

0.63

0.63

2.52

2023

0.68

0.68

- -

- -

- -

11/22/2022

Medtronic Stock Falls After Medical-Device Maker Posts Lower Earnings

The Wall Street Journal - Read more...

11/07/2022

Medtronic Blood-Pressure Device Curbs Hypertension, but Misses Top Goal in Study

The Wall Street Journal - Read more...

10/24/2022

Medtronic to Spin Off Units

The Wall Street Journal - Read more...

08/24/2021

Palo Alto Networks, CrowdStrike, Pinduoduo: What to Watch When the Stock Market Opens Today

The Wall Street Journal - Read more...

06/03/2021

Medtronic to Stop Selling Implantable Heart Pump Over Safety Concerns

The Wall Street Journal - Read more...